MondayJun 13, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) and the Budding Alternative Nicotine Market

The nicotine pouch market is projected to reach $21.84 billion in 2027, up from $2.33 billion in 2020, representing a CAGR of 30.7% The smokeless tobacco products sector is expected to post a CAGR of 7.2% over the forecast period (2018-2025) Lexaria, through its patented DehydraTECH technology, is tapping into this important alternative nicotine sector  Its management is confident that its research and technology development investment will pay off and provide greater consumer satisfaction. In 2019, it was estimated that at least 1.1 billion people globally smoked cigarettes regularly. 780 million, representing 71% of the global smoking population, noted that…

Continue Reading

WednesdayJun 08, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Adding to Cannabis Product Line, Research

Flora Growth is building on its cannabis brand globalization efforts with two partnerships that expand its product portfolio and its research efforts in the United States and United Kingdom Flora’s partnership with former NFL athlete Ricky Williams has delivered its first product — a cannabis one-hitter accessory designed to provide a unique experience emblematic of Williams’ active lifestyle brand The company’s acquisition of the Masaya CBD brand developed by a cell biologist on Flora’s board of directors gives the company a formulation suitable for its current clinical trial efforts in the United Kingdom, and a well-received brand designed to help…

Continue Reading

MondayJun 06, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Global Expansion Strategy with Cannabis Regulatory Veteran Holly Bell’s Appointment; Hosts Regulatory Webinar

Flora Growth has appointed regulatory veteran Holly Bell as the new Vice President of Regulatory Affairs Bell will help further the company’s domestic and global expansion strategy and lead government relations in key international markets She will also oversee the regulatory strategy supporting the advancement of the company’s cultivation, distribution, and pharmaceutical programs Bell also participated in the first event in her new position- the Florida Industrial Hemp Conference and Exhibition held on May 20-22, 2022 In recent months, Flora Growth (NASDAQ: FLGC) has been on an aggressive international expansion plan that has seen exports to Mexico and Spain, with…

Continue Reading

FridayJun 03, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Mines Potential of Helping Medicines Do What they Do, But Better

Lexaria Bioscience is a global innovator in drug delivery platforms, developing a technology designed to improve the performance of other medicinal products by making them more rapidly and effectively usable by patients’ bodies Lexaria’s patented DehydraTECH technology has been studied in combination with a number of other products, including but not limited to, cannabidiol (“CBD”), oral nicotine, antivirals, NSAIDs, and erectile dysfunction therapies The company is pursuing FDA approval under the Investigational New Drug (“IND”) process to clinically test its DehydraTECH-CBD for the treatment of high blood pressure A driving focus of the company’s R&D has been to improve the…

Continue Reading

WednesdayJun 01, 2022 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Consistently Enhancing the Oral Administration of Active Pharmaceutical Ingredients

A global innovator in drug delivery platforms, Lexaria has developed a patented technology, DehydraTECH(TM)  Through research, Lexaria has evidenced that DehydraTECH enhances the efficiency and speed of orally- administered fat-soluble active pharmaceutical ingredients (“APIs”) Lexaria is consistently enhancing the delivery of APIs that affect current oral formulations: speed of onset, limited absorption, and low membrane permeability Lexaria has conducted numerous ground-breaking studies, some of which open up the possibility of fast-acting oral products that avoid the lung diseases and cancers caused by inhalation of combusted molecules common in smoking Oral formulations account for approximately 90% of the global share of…

Continue Reading

FridayMay 27, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Growing Commercial Opportunities

Lexaria is a biotechnology company focused on licensing its proprietary DehydraTECH(TM) technology The DehydraTECH technology has been proven to increase the bioavailability, speed of onset and brain absorption of APIs, and improve customer experiences by masking unwanted tastes Lexaria has 25 patents granted worldwide and is pursuing numerous other pending patent applications The company operates several subsidiary companies to focus on different commercial opportunities  Ever since acquiring its first intellectual property (“IP”) that subsequently formed the basis of its first two patent application filings in 2014, biotechnology company Lexaria Bioscience (NASDAQ: LEXX) has grown the number of patents granted and…

Continue Reading

WednesdayMay 25, 2022 11:15 am

Flora Growth Corp. (NASDAQ: FLGC) Increases Vessel’s Footprint in the Canadian Cannabis Marketplace; Expands Its Operational Footprint in the E.U. and UK

Flora Growth’s Vessel brand just got listed on the Ontario Cannabis Store (“OCS”) Vessel also launched its direct-to-consumer online store to take control of its customer relationship journey Flora, through this expansion, seeks to tap into the growing Canadian cannabis market, which is valued at an estimated CAD 5.9 billion in 2022 The company has also expanded its operational footprint in Europe and the U.K. in a move that furthers its international growth strategy Flora Growth (NASDAQ: FLGC) just announced that its Vessel brand just got listed on the Ontario Cannabis Store (“OCS”) in a move that significantly increases the…

Continue Reading

WednesdayMay 25, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Making Waves in the Growing Antiviral Drug Space with its DehydraTECH Technology

Lexaria Bioscience Corp., through its patented DehydraTECH technology, is improving the way many drugs enter the bloodstream In June 2021, the company proved that an antiviral drug enhanced with its technology was effective at inhibiting the COVID-19/SARS-CoV-2 virus With the global antiviral market projected to hit $66.7 billion by 2025, Lexaria plans to capitalize on this growth by pushing its DehydraTECH technology and exploring multiple avenues of related application Today, it is estimated that infectious diseases account for a quarter to one-third of mortality globally. This has mainly been attributed to increased travel, globalization, populated cities, urbanization, and changes in…

Continue Reading

MondayMay 23, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Year-end Report Shows Significant Revenue and Profit Growth, with Expectations for Further Rapid Growth in 2022

Cannabis cultivator and distributor Flora Growth has announced its annual financial and operating results, showing “significantly higher” revenues and profit gain for 2021 over the previous year Flora maintains an outlook for 2022 of an additional 288 to 400 percent revenue growth by year end, largely driven by the company’s acquisition of consumer wellness brand JustCBD The JustCBD acquisition increased Flora’s reach to more than half a million consumers through 14,000 retail stores in the United States Flora’s operations are centered at its Cosechemos cultivation facility in central Colombia, where the company enjoys ideal growing conditions year-round and has easy…

Continue Reading

ThursdayMay 19, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC), A Company Revolutionizing the Plant-Based Wellness and Lifestyle Industry

Flora Growth has been building a design-led collective of plant-based wellness and lifestyle brands Through the work done by its pharma division, the company earned over $31.5 million in gross proceeds in the year ended November 2021 The company still maintains its revenue guidance projection of $35-45 million for 2022, attributed mainly to product diversification initiatives, strengthening its supply chain, and adoption of cost-effective cultivation practices Since its inception, Flora Growth (NASDAQ: FLGC) has remained committed to building a design-led collective of plant-based wellness and lifestyle brands. This objective has defined Flora Growth’s three central pillars- wholesale cannabis, pharmaceutical cannabis,…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977